Publications by authors named "David Fairlamb"

Claim this Profile
T
The Potential Role for a Painless Enzymatic Debridement Gel in Wound Bed Preparation for Venous Leg Ulcers-A Dose Escalation Study.
David Goldsmith, David M Fairlamb

Int Wound J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers.
David M Fairlamb, Kinga Szepeshazi, David Goldsmith, Peter Danos, Hadar Lev-Tov

Int Wound J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary evidence supporting a new enzymatic debridement product for use in chronic wounds.
David M Fairlamb, Bela Kelety, Anke Bachert, Anika Scholtissek, Richard D Jones

Int Wound J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring.
Nick L Occleston, Sharon O'Kane, Hugh G Laverty, Mark Cooper, David Fairlamb

Wound Repair Regen· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of avotermin (transforming growth factor β3) in a clinically relevant pig model of long, full-thickness incisional wounds.
Hugh G Laverty, Nick L Occleston, Mark Johnson, John Little, Richard Jones, David Fairlamb

J Cutan Med Surg· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area.
Nick L Occleston, David Fairlamb, John Hutchison, Sharon O'Kane, Mark W J Ferguson

Expert Opin Investig Drugs· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised comparison of radical radiotherapy with or without chemotherapy for patients with non-small lung cancer: results from the Big Lung Trial.
David Fairlamb, Robert Milroy, Nicole Gower, Mahesh Parmar, Michael Peake

Radiother Oncol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis